White Matter Hyperintensities Modify CYP2C19 Effect on Stroke Progression in Small Vessel Occlusion
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: The association between CYP2C19 loss-of-function (LOF) alleles and early neurological deterioration (END) in acute small vessel occlusion (SVO) patients receiving dual antiplatelet therapy (DAPT) remains inconsistent. We hypothesized that white matter hyperintensities (WMH) burden act as a key moderator and investigated whether this modulates the association between CYP2C19 LOF and END. METHODS: We conducted a retrospective study of SVO patients receiving DAPT. CYP2C19 genotypes were classified as LOF carriers or non-carriers. The primary endpoint was END; secondary and safety endpoints included severe END, 90-day mRS 0-2, symptomatic intracranial hemorrhage (sICH), bleeding, and mortality. Multivariable regression and interaction analyzes assessed associations between CYP2C19, WMH, and clinical outcomes. RESULTS: A total of 247 patients (median age 67.0 years; 28.7% female; 60.7% CYP2C19 LOF carriers), 54 (21.9%) experienced END. Multivariable analysis identified infarct diameter (aOR 1.26, 95% CI 1.13-1.39, p < 0.001) and total cerebral small vessel disease (CSVD) burden (aOR 2.02, 95% CI 1.37-2.98, p < 0.001) as independent predictors. A significant multiplicative interaction was observed between CYP2C19 LOF and severe WMH on END risk (aOR 9.34, 95% CI 2.06-48.10, p = 0.005). Stratified analysis showed CYP2C19 LOF significantly increased END risk specifically in patients with severe WMH (aOR 3.44, 95% CI 1.12-10.55, p = 0.030), but not mild WMH. Predicted probability curves suggested a Fazekas score threshold of approximately 2.70. Secondary and safety outcomes were infrequent. CONCLUSIONS: CYP2C19 LOF alleles increase END risk in SVO patients specifically with severe WMH. These findings highlight the value of integrating genetic and neuroimaging markers for risk stratification and personalized antiplatelet therapy.
DOI: 10.1002/acn3.70579
Institutions: Capital Medical University, Beijing Geriatric Hospital
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: white matter hyperintensities, CYP2C19 loss-of-function alleles, small vessel occlusion, early neurological deterioration, dual antiplatelet therapy, cerebral small vessel disease, Fazekas score, genetic moderators, stroke progression, risk stratification, symptomatic intracranial hemorrhage, mortality, acute ischemic stroke
Open Access status: gold
Estimated APC paid: $4,100
OpenAlex ID: W7232398846
